TY - JOUR
T1 - Characterization of fibroblast-specific protein 1 in pulmonary fibrosis
AU - Lawson, William E.
AU - Polosukhin, Vasiliy V.
AU - Zoia, Ornella
AU - Stathopoulos, Georgios T.
AU - Han, Wei
AU - Plieth, David
AU - Loyd, James E.
AU - Neilson, Eric G.
AU - Blackwell, Timothy S.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2005/4/15
Y1 - 2005/4/15
N2 - Because fibroblasts produce collagen and other extracellular matrix components that are deposited during tissue fibrosis, defining the behavior of these cells is critical to understanding the pathogenesis of fibrotic diseases. We investigated the utility of fibroblast-specific protein 1 (FSP1), a member of the calmodulin S100 troponin C superfamily, for identifying lung fibroblasts in a murine model of pulmonary fibrosis induced by intratracheal administration of bleomycin. Protein and mRNA expression of FSP1 was minimal in untreated lungs, but increased by 1 week after bleomycin administration and remained increased at 2 and 3 weeks after treatment. By immunohistochemistry, the number of FSP1 + cells increased in a dose-dependent manner in the lungs after bleomycin treatment. Colocalization of α1 procollagen and FSP1 in interstitial cells demonstrated that FSP1+ fibroblasts contribute to the deposition of collagen after bleomycin administration. In primary lung cell cultures, lung fibroblasts, but not macrophages or type II alveolar epithelial cells, expressed FSP1. FSP1 also identified fibroblasts in lung biopsy specimens from patients with documented usual interstitial pneumonitis. Therefore, FSP1 is an improved marker for lung fibroblasts that could be useful for investigating the pathogenesis of pulmonary fibrosis.
AB - Because fibroblasts produce collagen and other extracellular matrix components that are deposited during tissue fibrosis, defining the behavior of these cells is critical to understanding the pathogenesis of fibrotic diseases. We investigated the utility of fibroblast-specific protein 1 (FSP1), a member of the calmodulin S100 troponin C superfamily, for identifying lung fibroblasts in a murine model of pulmonary fibrosis induced by intratracheal administration of bleomycin. Protein and mRNA expression of FSP1 was minimal in untreated lungs, but increased by 1 week after bleomycin administration and remained increased at 2 and 3 weeks after treatment. By immunohistochemistry, the number of FSP1 + cells increased in a dose-dependent manner in the lungs after bleomycin treatment. Colocalization of α1 procollagen and FSP1 in interstitial cells demonstrated that FSP1+ fibroblasts contribute to the deposition of collagen after bleomycin administration. In primary lung cell cultures, lung fibroblasts, but not macrophages or type II alveolar epithelial cells, expressed FSP1. FSP1 also identified fibroblasts in lung biopsy specimens from patients with documented usual interstitial pneumonitis. Therefore, FSP1 is an improved marker for lung fibroblasts that could be useful for investigating the pathogenesis of pulmonary fibrosis.
KW - Bleomycin
KW - Collagen
KW - Lung
KW - Mouse
KW - α-smooth muscle actin
UR - http://www.scopus.com/inward/record.url?scp=17644396081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17644396081&partnerID=8YFLogxK
U2 - 10.1164/rccm.200311-1535OC
DO - 10.1164/rccm.200311-1535OC
M3 - Article
C2 - 15618458
AN - SCOPUS:17644396081
SN - 1073-449X
VL - 171
SP - 899
EP - 907
JO - American journal of respiratory and critical care medicine
JF - American journal of respiratory and critical care medicine
IS - 8
ER -